Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Lecanemab Access, Diabetes and Brain Health, and Global Life Expectancy Trends
In this episode, Dr. Chi-Ming Chow begins with an introduction to the latest medical updates. He discusses the use of lecanemab in Alzheimer's treatment, highlighting access disparities. The conversation moves to the impact of Type 2 diabetes mellitus on brain health. Dr. Chow explores the ongoing debate over universal health care in Maine and shares insights into a gene editing breakthrough for rare genetic disorders. A WHO report on the global decline in life expectancy is examined, followed by a discussion on Amy Larocca's book about the wellness industry. The episode concludes with closing remarks and a sign-off.
Key Points
- Significant disparities exist in the use of the new Alzheimer's treatment lecanemab, with affluent, urban, white men predominantly benefiting from this expensive therapy.
- A study has linked type 2 diabetes mellitus to cortical thinning in the brain, especially among Hispanic populations, underscoring the need for targeted diabetes management to protect cognitive health.
- The case of KJ Muldoon demonstrates the promising potential of personalized gene editing therapies for rare genetic disorders, offering hope for more effective and affordable treatments in the future.
Chapters
| 0:00 | |
| 0:25 | |
| 3:06 | |
| 6:53 | |
| 11:31 | |
| 15:00 | |
| 17:58 | |
| 20:29 |
Transcript
Loading transcript...
- / -